FreshPatents.com Logo
stats FreshPatents Stats
1 views for this patent on FreshPatents.com
2012: 1 views
Updated: April 14 2014
newTOP 200 Companies filing patents this week


    Free Services  

  • MONITOR KEYWORDS
  • Enter keywords & we'll notify you when a new patent matches your request (weekly update).

  • ORGANIZER
  • Save & organize patents so you can view them later.

  • RSS rss
  • Create custom RSS feeds. Track keywords without receiving email.

  • ARCHIVE
  • View the last few months of your Keyword emails.

  • COMPANY DIRECTORY
  • Patents sorted by company.

AdPromo(14K)

Follow us on Twitter
twitter icon@FreshPatents

Compounds for the treatment of multi-drug resistant bacterial infections

last patentdownload pdfdownload imgimage previewnext patent


Title: Compounds for the treatment of multi-drug resistant bacterial infections.
Abstract: The present invention relates to compounds that demonstrate antibacterial activity, processes for their preparation, pharmaceutical compositions containing them as the active ingredient, to their use as medicaments and to their use in the manufacture of medicaments for use in the treatment of bacterial infections in warm-blooded animals such as humans. In particular this invention relates to compounds useful for the treatment of bacterial infections in warm-blooded animals such as humans, more particularly to the use of these compounds in the manufacture of medicaments for use in the treatment of bacterial infections in warm-blooded animals such as humans. ...


Browse recent Astrazeneca Ab patents - Sodertalje, SE
Inventors: Gloria Breault, Charles Joseph Eyermann, Bolin Geng, Marshall Morningstar, Folkert Reck
USPTO Applicaton #: #20120108577 - Class: 5142242 (USPTO) - 05/03/12 - Class 514 
Drug, Bio-affecting And Body Treating Compositions > Designated Organic Active Ingredient Containing (doai) >Heterocyclic Carbon Compounds Containing A Hetero Ring Having Chalcogen (i.e., O,s,se Or Te) Or Nitrogen As The Only Ring Hetero Atoms Doai >Hetero Ring Is Six-membered And Includes At Least Nitrogen And Sulfur As Ring Members >Polycyclo Ring System Having The Six-membered Hetero Ring As One Of The Cyclos (e.g., 1,3- And 1,4- Benzothiazines, Etc.)

view organizer monitor keywords


The Patent Description & Claims data below is from USPTO Patent Application 20120108577, Compounds for the treatment of multi-drug resistant bacterial infections.

last patentpdficondownload pdfimage previewnext patent

BACKGROUND OF THE INVENTION

The international health community continues to express serious concern that the evolution of antibacterial resistance will result in strains against which currently available antibacterial agents will be ineffective. For example, resistant strains of Gram-positive pathogens such as methicillin-resistant Staphylococcus aureus (MRSA), methicillin-resistant coagulase-negative staphylococci (MRCNS), penicillin-resistant Streptococcus pneumoniae and multiple resistant Enterococcus faecium are both difficult to treat and difficult to eradicate. Consequently, in order to overcome the threat of widespread multi-drug resistant organisms, there is an on-going need to develop new antibiotics, particularly those with either a novel mechanism of action and/or containing new pharmacophoric groups.

SUMMARY

OF THE INVENTION

These and other needs are met by the invention disclosed herein which is directed to a compound of formula I:

L-U1-M-U2-R  I

or a pharmaceutically acceptable salt thereof, or N-oxides thereof, wherein:

L is a group of formula L1-L15:

” indicates the point of attachment;

Z3, Z6, and Z7 are C or N provided that when Z3, Z6, or Z7 is N, then R2a, R2c, or R2d are absent;

R2a, R2b, R2c, R2d, R2e, and R2f, are each independently H, halo, cyano, carboxy, nitro, carbamoyl, —CO—(C1-C6)alkyl, CO2—(C1-C6)alkyl, (C1-C6)alkyl, hydroxy, halo(C1-C6)alkyl, halo(C1-C6)alkoxy, (C1-C6)alkoxy, NHCO—(C1-C6)alkyl, SO2(C1-C6)alkyl, SO2NH(C1-C6)alkyl, or SO2N((C1-C6)alkyl)2;

R2g, R2g′, and R2g″ are each independently H, (C1-C6)alkyl, or halo(C1-C6)alkyl;

U1 is CRaRb-CRcRd or CRaRb-CRcRd-CReRf, wherein Ra, Rb, Rc, Rd, Re, and Rf are each independently hydrogen or (C1-C6)alkyl;

M is a group of formula M1-M5:



Download full PDF for full patent description/claims.

Advertise on FreshPatents.com - Rates & Info


You can also Monitor Keywords and Search for tracking patents relating to this Compounds for the treatment of multi-drug resistant bacterial infections patent application.
###
monitor keywords



Keyword Monitor How KEYWORD MONITOR works... a FREE service from FreshPatents
1. Sign up (takes 30 seconds). 2. Fill in the keywords to be monitored.
3. Each week you receive an email with patent applications related to your keywords.  
Start now! - Receive info on patent apps like Compounds for the treatment of multi-drug resistant bacterial infections or other areas of interest.
###


Previous Patent Application:
Heterocyclic-substituted piperidine compounds and the uses thereof
Next Patent Application:
Thiazole compounds and methods of use
Industry Class:
Drug, bio-affecting and body treating compositions
Thank you for viewing the Compounds for the treatment of multi-drug resistant bacterial infections patent info.
- - - Apple patents, Boeing patents, Google patents, IBM patents, Jabil patents, Coca Cola patents, Motorola patents

Results in 1.21129 seconds


Other interesting Freshpatents.com categories:
Software:  Finance AI Databases Development Document Navigation Error -g2--0.7116
     SHARE
  
           

FreshNews promo


stats Patent Info
Application #
US 20120108577 A1
Publish Date
05/03/2012
Document #
13348143
File Date
01/11/2012
USPTO Class
5142242
Other USPTO Classes
514302, 514312, 5142305
International Class
/
Drawings
0



Follow us on Twitter
twitter icon@FreshPatents